NASDAQ
Igene Biotechnology, Inc. (IGNE) has a eps (basic) of $-0.00 as of Thursday, December 31, 2009. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.